Krishna Yeshwant

Companies

• Parabilis Medicines, Inc.Board member Jun 9, 2026 to now¹
• Verve Therapeutics, Inc.Board member Jun 16, 2021 to now²
• EQRx, Inc.Board member Dec 20, 2021 to Nov 9, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• VTVerve Therapeutics, Inc.0 shares⁴Jul 25, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 25, 2025U 1,800,000 shares of Verve Therapeutics, Inc.⁴
• Jul 25, 2025U 4,260,047 shares of Verve Therapeutics, Inc.⁴
• Jul 25, 2025U 6,108,442 shares of Verve Therapeutics, Inc.⁴
• Dec 1, 2023Bought 1,800,000 shares at $10.00 of Verve Therapeutics, Inc.⁵
• Nov 4, 2022Sold 243 shares at $32.90 of Verve Therapeutics, Inc.⁶
• Nov 4, 2022Sold 650 shares at $31.99 of Verve Therapeutics, Inc.⁶
• Nov 4, 2022Sold 47,690 shares at $31.12 of Verve Therapeutics, Inc.⁶
• Nov 4, 2022Other 48,583 shares of Verve Therapeutics, Inc.⁶
• Nov 3, 2022Sold 1,755 shares at $33.84 of Verve Therapeutics, Inc.⁷
• Nov 3, 2022Sold 25,534 shares at $33.14 of Verve Therapeutics, Inc.⁷
• Nov 3, 2022Sold 22,279 shares at $32.32 of Verve Therapeutics, Inc.⁷
• Nov 3, 2022Other 49,569 shares of Verve Therapeutics, Inc.⁷
• Nov 2, 2022Sold 8,930 shares at $36.78 of Verve Therapeutics, Inc.⁷
• Nov 2, 2022Sold 10,372 shares at $36.28 of Verve Therapeutics, Inc.⁷
• Nov 2, 2022Sold 9,350 shares at $34.78 of Verve Therapeutics, Inc.⁷
• Nov 2, 2022Other 28,651 shares of Verve Therapeutics, Inc.⁷
• Nov 1, 2022Sold 260 shares at $38.64 of Verve Therapeutics, Inc.⁸
• Nov 1, 2022Sold 2,377 shares at $37.82 of Verve Therapeutics, Inc.⁸
• Nov 1, 2022Sold 29,326 shares at $36.69 of Verve Therapeutics, Inc.⁸
• Nov 1, 2022Other 31,963 shares of Verve Therapeutics, Inc.⁸
• Oct 31, 2022Sold 88 shares at $40.64 of Verve Therapeutics, Inc.⁸
• Oct 31, 2022Sold 6,601 shares at $40.16 of Verve Therapeutics, Inc.⁸
• Oct 31, 2022Sold 23,275 shares at $38.94 of Verve Therapeutics, Inc.⁸
• Oct 31, 2022Sold 23,732 shares at $37.91 of Verve Therapeutics, Inc.⁸
• Oct 31, 2022Other 53,697 shares of Verve Therapeutics, Inc.⁸